Exhibit 10.2
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY
STATE AND, EXCEPT AS SET FORTH IN SECTIONS 6.3 AND 6.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL
REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, SUCH OFFER,
SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
STOCK PURCHASE WARRANT
Company: KORU Medical Systems, Inc., a Delaware corporation
Number of Shares: As set forth in Section 1 below
Class/Series of Stock: Common Stock, $0.01 par value per share
Exercise Price: $2.12 per Share, subject to adjustment as provided
herein
Issue Date: March 8, 2024
Expiration Date: March 7, 2034
Credit Facility: This Stock Purchase
Warrant (as amended and in effect from time to time, this “Warrant”) is issued in connection with that certain Loan
and Security Agreement of even date herewith among HSBC Ventures USA Inc., the Company and the other parties named therein (as amended
and/or modified and in effect from time to time, the “Loan Agreement”).
THIS WARRANT PROVIDES THAT, for
good and valuable consideration, HSBC VENTURES USA INC. (together with any successor or permitted assignee or transferee of this Warrant
or of any shares issued upon exercise hereof, “Holder”) is entitled to purchase from the above-named company (the “Company”)
up to the number of fully paid and non-assessable shares of the above-stated class/series of stock (the “Class”) set
forth in Section 1 below, at a purchase price per Share equal to the above-stated exercise price (the “Exercise Price”),
subject to the provisions and upon the terms and conditions set forth in this Warrant.
SECTION 1. NUMBER OF SHARES.
1.1 Number
of Shares. This Warrant shall be exercisable for the Initial Shares, plus the Additional Shares, if any
(collectively, and as may be adjusted from time to time in accordance with the provisions of this Warrant, the “Shares”).
1.2 Initial
Shares. As used herein, “Initial Shares” means 38,052 shares of the Class, subject
to adjustment from time to time in accordance with the provisions of this Warrant.
1.3 Additional
Shares. Upon the making, if any, of the first Term Loan Advance (as defined in the Loan Agreement) to
the Company in any amount, this Warrant automatically shall become exercisable for an additional 38,052 shares of the Class, as such number
may be adjusted from time to time in accordance with the provisions of this Warrant (the “Additional Shares”), including,
without limitation, adjustments in respect of events occurring prior to the date, if any, on which this Warrant becomes exercisable for
such shares as if they constituted “Shares” hereunder for such purpose at all times from the Issue Date.
SECTION 2. EXERCISE.
2.1 Method
of Exercise. Holder may exercise this Warrant in whole or in part at any time and from time to time prior to the expiration or earlier
termination hereof by delivering to the Company the original of this Warrant together with a duly executed Notice of Exercise in substantially
the form attached hereto as Appendix 1 and, unless Holder is exercising this Warrant pursuant to a cashless exercise set forth
in Section 2.2, a check, wire transfer of same-day funds (to an account designated by the Company), or other form of payment acceptable
to the Company for the aggregate Exercise Price for the Shares being purchased. Notwithstanding any contrary provision herein, if this
Warrant was originally executed and/or delivered
electronically, in no event shall Holder be required
to surrender or deliver an ink-signed paper copy of this Warrant in connection with its exercise hereof or of any rights hereunder, nor
shall Holder be required to surrender or deliver a paper or other physical copy of this Warrant in connection with any exercise hereof.
2.2 Cashless
Exercise. On any exercise of this Warrant, in lieu of payment of the aggregate Exercise Price in the manner specified in Section 2.1
above (but otherwise in accordance with the requirements of such Section), Holder may elect to surrender to the Company Shares having
an aggregate value equal to the aggregate Exercise Price. If Xxxxxx makes such election, the Company shall issue to Holder such number
of fully paid and non-assessable Shares determined by the following formula:
X = Y(A-B)/A
where:
| |
X = |
the number of Shares to be issued to Holder; |
| |
|
|
| |
Y = |
the number of Shares with respect to which this Warrant is being exercised (inclusive of the Shares surrendered to the Company in payment of the aggregate Exercise Price); |
| |
|
|
| |
A = |
the then-fair market value (as determined pursuant to Section 2.3 below) of one Share; and |
| |
|
|
| |
B = |
the then-effective Exercise Price. |
2.3 Fair
Market Value. If shares of the Class are then traded or quoted on a nationally recognized securities exchange, inter-dealer quotation
system or over-the-counter market (a “Trading Market”), the fair market value of a Share shall be the closing
price or last sale price of a share of the Class reported for the Business Day immediately before the date on which Holder delivers this
Warrant together with its Notice of Exercise to the Company. If shares of the Class are not then traded in a Trading Market, the Board
of Directors of the Company shall determine the fair market value of a Share in its reasonable good faith judgment.
2.4 Delivery
of Certificate and New Warrant. Within a reasonable time after Holder exercises this Warrant in the manner set forth in Section 2.1
or 2.2 above, the Company shall deliver to Holder a certificate, which may be in electronic form (or, in the case of uncertificated securities,
provide notice of book entry) representing the Shares issued to Holder upon such exercise and, if this Warrant has not been fully exercised
and has not expired, a new warrant of like tenor representing the Shares not so acquired (or surrendered in payment of the aggregate Exercise
Price).
2.5 Replacement
of Warrant.
(a) Paper
Original Warrant. To the extent that the original of this Warrant is a paper original, on receipt of evidence reasonably satisfactory
to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery
of an indemnity agreement reasonably satisfactory in form, substance and amount to the Company or, in the case of mutilation, on surrender
of this Warrant to the Company for cancellation, the Company shall, within a reasonable time, execute and deliver to Holder, in lieu of
this Warrant, a new warrant of like tenor and amount.
(b) Electronic
Original Warrant. To the extent that the original of this Warrant is an electronic original, if at any time this Warrant is rejected
by any person (including, but not limited to, paying or escrow agents) or any such person fails to comply with the terms of this Warrant
based on this Warrant being presented to such person as an electronic record or a printout hereof, or any signature hereto being in electronic
form, the Company shall, promptly upon Xxxxxx’s request and without indemnity, execute and deliver to Holder,
- 2 -
in lieu of electronic original versions of this Warrant,
a new warrant of like tenor and amount in paper form with original ink signatures.
2.6 Treatment
of Warrant Upon Acquisition of Company.
(a) Acquisition.
For the purpose of this Warrant, “Acquisition” means any transaction or series of related transactions involving:
(i) the sale, lease, exclusive license, or other disposition of all or substantially all of the assets of the Company; (ii) any merger
or consolidation of the Company into or with another person or entity (other than a merger or consolidation effected exclusively to change
the Company’s domicile), or any other corporate reorganization, in which the stockholders of the Company in their capacity as such
immediately prior to such merger, consolidation or reorganization, own less than a majority of the Company’s (or the surviving or
successor entity’s) outstanding voting power immediately after such merger, consolidation or reorganization; (iii) any merger, consolidation
or other business combination of the Company into or with a special purpose acquisition company or wholly-owned subsidiary thereof; or
(iv) any sale or other transfer by the stockholders of the Company of shares representing a majority of the Company’s then-total
outstanding combined voting power. For the avoidance of doubt, “Acquisition” shall not include any sale and issuance by the
Company of shares of its capital stock or of securities or instruments exercisable for or convertible into, or otherwise representing
the right to acquire, shares of its capital stock to one or more investors for cash in a transaction or series of related transactions
the primary purpose of which is a bona fide equity financing of the Company.
(b) Treatment
of Warrant in Cash/Public Company Acquisition. In the event of an Acquisition in which the consideration to be received by the holders
of the outstanding shares of the Class (in their capacity as such) consists solely of cash, solely of Marketable Securities (as hereinafter
defined) or a combination of cash and Marketable Securities (a “Cash/Public Company Acquisition”), and the fair market
value of one Share as determined in accordance with Section 2.3 above would be greater than the Exercise Price in effect as of immediately
prior to the closing of such Cash/Public Company Acquisition, and Holder has not previously exercised this Warrant in full, then, in lieu
of Holder’s exercise of the unexercised portion of this Warrant, this Warrant shall, as of immediately prior to such closing (but
subject to the occurrence thereof), automatically cease to represent the right to purchase Shares and shall, from and after such closing,
represent solely the right to receive the aggregate consideration that would have been payable in such Cash/Public Company Acquisition
on and in respect of all Shares for which this Warrant was exercisable as of immediately prior to the closing thereof, net of the aggregate
Exercise Price therefor, as if such Shares had been issued and outstanding to Holder as of immediately prior to such closing, as and when
such consideration is paid to the holders of the outstanding shares of the Class. In the event of a Cash/Public Company Acquisition in
which the fair market value of one Share as determined in accordance with Section 2.3 above would be equal to or less than the Exercise
Price in effect as of immediately prior to the closing of such Cash/Public Company Acquisition, then this Warrant will automatically and
without further action of any party terminate as of immediately prior to such closing.
(c) Treatment
of Warrant in non-Cash/Public Company Acquisition. Upon the closing of any Acquisition other than a Cash/Public Company Acquisition,
the acquiring, surviving or successor entity shall assume this Warrant and the Company’s obligations hereunder, and this Warrant
shall thereafter be exercisable for the same securities and/or other property as would have been paid for the Shares issuable upon exercise
of the unexercised portion of this Warrant as if such Shares were outstanding on and as of the closing of such Acquisition, at an aggregate
Exercise Price equal to the aggregate Exercise Price in effect as of immediately prior to such closing, all subject to further adjustment
from time to time thereafter in accordance with the provisions of this Warrant.
(d) As
used in this Warrant, “Marketable Securities” means securities meeting all of the following requirements (determined
as of immediately prior to the closing of the Acquisition): (i) the issuer thereof is then subject to the reporting requirements of Section
13 or Section 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is then current in
its filing of all required reports and other information under the Act and the Exchange Act; (ii) the class and series of shares or other
security of the issuer
- 3 -
that would be received by Holder in connection with
the Acquisition were Holder to exercise this Warrant on or prior to the closing thereof is then traded in a Trading Market; and (iii)
following the closing of such Acquisition, Holder would not be restricted from publicly re-selling all of the issuer’s shares and/or
other securities that would be received by Holder in such Acquisition were Holder to exercise this Warrant in full on or prior to the
closing of such Acquisition, except to the extent that any such restriction (x) arises solely under federal or state securities laws,
rules or regulations, and (y) does not extend beyond six (6) months from the closing of such Acquisition. Notwithstanding the foregoing
provisions of this Section 2.6(d), securities held in escrow or subject to holdback to cover indemnification-related claims shall be deemed
to be Marketable Securities if they would otherwise be Marketable Securities but for the fact that they are held in escrow or subject
to holdback to cover indemnification-related claims.
SECTION 3. CERTAIN ADJUSTMENTS TO THE SHARES, CLASS
AND EXERCISE PRICE.
3.1 Stock
Dividends, Splits, Etc. If the Company declares or pays a dividend or distribution on the outstanding shares of the Class payable
in additional shares of the Class or other securities or property (other than cash), then upon exercise of this Warrant, for each Share
acquired, Holder shall receive, without additional cost to Holder, the total number and kind of securities and property which Holder would
have received had Holder owned the Shares of record as of the date the dividend or distribution occurred. If the Company subdivides the
outstanding shares of the Class by reclassification or otherwise into a greater number of shares, the number of Shares purchasable hereunder
shall be proportionately increased and the Exercise Price shall be proportionately decreased. If the outstanding shares of the Class are
combined or consolidated, by reclassification or otherwise, into a lesser number of shares, the Exercise Price shall be proportionately
increased and the number of Shares shall be proportionately decreased.
3.2 Reclassification,
Exchange, Combinations or Substitution. Upon any event whereby all of the outstanding shares of the Class are reclassified, exchanged,
combined, substituted, or replaced for, into, with or by Company securities of a different class and/or series, then from and after the
consummation of such event, “Class” shall mean such securities and this Warrant will be exercisable for the number of such
securities that Holder would have received had the Shares been outstanding on and as of the consummation of such event, at an aggregate
Exercise Price equal to the aggregate Exercise Price in effect as of immediately prior to such event, all subject to further adjustment
thereafter from time to time in accordance with the provisions of this Warrant. The provisions of this Section 3.2 shall similarly apply
to successive reclassifications, exchanges, combinations, substitutions, replacements or other similar events.
3.3 Adjustment
to Exercise Price on Cash Dividend. In the event that the Company at any time or from time to time prior to the exercise in full of
this Warrant pays any cash dividend on the outstanding shares of the Class or makes any cash distribution on or in respect of all outstanding
shares of the Class (other than a distribution of cash proceeds received by the Company in connection with an Acquisition described in
Section 2.6(a)(i) above), then on and as of the date of each such dividend payment and/or distribution, the Exercise Price shall be reduced
by an amount equal to the amount paid or distributed upon or in respect of each outstanding share of the Class; provided that in no event
shall the Exercise Price be reduced below the then-par value, if any, of a share of the Class.
3.4 No
Fractional Share. No fractional Share shall be issued upon exercise of this Warrant, and the number of Shares to be issued shall be
rounded down to the nearest whole Share. If a fractional Share interest arises upon any exercise of this Warrant, the Company shall eliminate
such fractional Share interest by paying Holder in cash an amount equal to (a) such fractional interest, multiplied by (b)(i) the fair
market value (as determined in accordance with Section 2.3 above) of a full Share, less (ii) the then-effective Exercise Price.
3.5 Certificate
as to Adjustments. Within a reasonable time following each adjustment of the Exercise Price, Class and/or number of Shares pursuant
to the terms of this Warrant, the Company at its expense shall deliver a certificate of its Chief Financial Officer or other authorized
officer to Holder setting forth the adjustments to the Exercise Price, Class and/or number of Shares and the facts upon which such adjustments
are based. The Company shall, at any time and from time to time within a reasonable time following Xxxxxx’s written
- 4 -
request and at the Company’s expense, furnish
Holder with a certificate of its Chief Financial Officer or other authorized officer setting forth the then-current Exercise Price, Class
and number of Shares and the computations or other determinations thereof.
SECTION 4. REPRESENTATIONS AND COVENANTS OF THE
COMPANY.
4.1 Representations
and Warranties. The Company represents and warrants to, and agrees with, Xxxxxx as follows:
(a) [Reserved]
(b) The
number of Initial Shares first set forth above together with the number of Additional Shares first set forth above collectively represent
not less than 0.150% of the Company’s total issued and outstanding shares of capital stock, calculated on and as of the Issue Date
hereof on a fully-diluted, common stock-equivalent basis (but without excluding shares of capital stock that are not convertible into
shares of common stock) assuming (i) the conversion into common stock of all outstanding securities and instruments (including, without
limitation, securities deemed to be outstanding pursuant to clause (ii) of this Section 4.1(b)) convertible by their terms into shares
of common stock (regardless of whether such securities or instruments are by their terms now so convertible); (ii) the exercise in full
of all outstanding options, warrants (including, without limitation, this Warrant) and other rights to purchase or acquire shares of common
stock or securities exercisable for or convertible into shares of common stock (regardless of whether such options, warrants or other
rights to purchase or acquire are by their terms now exercisable); and (iii) the inclusion of all shares of common stock reserved for
issuance under all of the Company’s incentive stock and stock option plans and not now subject to outstanding grants or options.
(c) All
Shares which may be issued upon the exercise of this Warrant, shall, upon issuance, be duly authorized, validly issued, fully paid and
non-assessable, and free of any liens and encumbrances except for restrictions on transfer provided for herein or under applicable federal
and state securities laws. The Company covenants that it shall at all times cause to be reserved and kept available out of its authorized
and unissued capital stock such number of shares of the Class and other securities as will be sufficient to permit the exercise in full
of this Warrant.
(d) The
Company’s capitalization table attached hereto as Schedule 1 is true and complete, in all material respects, as of the Issue
Date.
4.2 Notice
of Certain Events. If the Company proposes at any time to:
(a) declare any dividend or distribution
upon the outstanding shares of the Class, whether in cash, stock or other securities or property and whether or not a regular cash dividend;
(b) offer for subscription or
sale pro rata to all holders of the outstanding shares of the Class any additional securities of the Company (other than pursuant to contractual
pre-emptive or first refusal rights);
(c) effect any reclassification,
exchange, combination, substitution, reorganization or recapitalization of the outstanding shares of the Class; or
(d) effect an Acquisition, or
to liquidate, dissolve or wind up the Company; or
then, in connection with each such event, the Company
shall give Holder notice thereof at the same time and in the same manner as it notifies holders of the outstanding shares of the Class.
4.3 Certain
Company Information. The Company will provide such information requested by Xxxxxx from time to time, within a reasonable time following
each such request, that is reasonably necessary to
- 5 -
enable Holder to comply with Holder’s accounting
or reporting requirements. Xxxxxx agrees to treat and hold all information provided by the Company pursuant to this Warrant in confidence
in accordance with the provisions of Section 12.9 of the Loan Agreement (regardless of whether the Loan Agreement shall then be in effect).
4.4 Put
Right. Holder shall have the one-time right (but not the obligation), exercisable in its sole discretion on written notice to the
Company (the “Put Notice”) at any time prior to the earlier to occur of (i) exercise in full of this Warrant, and (ii)
the expiration or termination of this Warrant, to require the Company to repurchase all (but not less than all) of the unexercised portion
of this Warrant from Holder (and the Company hereby agrees to repurchase this Warrant from Holder upon exercise of such right), free and
clear of all liens, claims and encumbrances (except such as may arise by or through the Company), for a total aggregate purchase price
of One Dollar ($1.00), such purchase price to be paid by the Company to Holder in cash or by the Company’s check at the Put Closing
against surrender by Holder to the Company at or prior to the Put Closing of the original of this Warrant (which may be in electronic
form), duly endorsed for transfer on the books of the Company or accompanied by duly executed share transfer powers and/or other instruments
of assignment or transfer (the “Put Right”). As used herein, “Put Closing” means the closing of
the sale and purchase of this Warrant pursuant to Holder’s exercise of the Put Right, on such date (the “Put Closing Date”)
as shall be set forth in Holder’s Put Notice, which date shall be not less than five (5) days following the date of such Put Notice.
Notwithstanding anything to the contrary herein, in the event that Holder exercises the Put Right, then on and after the Put Closing Date,
regardless of whether the Company shall have tendered payment of the purchase price thereat, this Warrant shall be deemed to have been
sold, assigned and transferred by Holder to the Company and shall be the Company’s sole and exclusive property.
SECTION 5. REPRESENTATIONS AND COVENANTS OF HOLDER.
Xxxxxx
represents and warrants to, and agrees with, the Company as follows:
5.1 Investment
Representations.
(a) Purchase
for Own Account. This Warrant and the Shares to be acquired upon exercise hereof are being acquired for investment for Xxxxxx’s
account, not as a nominee or agent, and not with a view to the public resale or distribution within the meaning of the Act. Holder also
represents that it has not been formed for the specific purpose of acquiring this Warrant or the Shares.
(b) Disclosure
of Information. Xxxxxx is aware of the Company’s business affairs and financial condition and has received or has had full access
to all the information it considers necessary or appropriate to make an informed investment decision with respect to the acquisition of
this Warrant and its underlying securities. Xxxxxx further has had an opportunity to ask questions of and receive answers from the Company
regarding the terms and conditions of the offering of this Warrant and its underlying securities and to obtain additional information
(to the extent the Company possessed such information or could acquire it without unreasonable effort or expense) necessary to verify
any information furnished to Holder or to which Holder has access.
(c) Investment
Experience. Holder understands that the purchase of this Warrant and its underlying securities involves substantial risk. Holder has
experience as an investor in securities of companies in the development stage and acknowledges that Holder can bear the economic risk
of such Holder’s investment in this Warrant and its underlying securities for an indefinite period of time, and has such knowledge
and experience in financial or business matters that Holder is capable of evaluating the merits and risks of its investment in this Warrant
and its underlying securities and/or has a preexisting personal or business relationship with the Company and certain of its officers,
directors or controlling persons of a nature and duration that enables Holder to be aware of the character, business acumen and financial
circumstances of such persons.
(d) Accredited
Investor Status. Holder is an “accredited investor” within the meaning of Regulation D promulgated under the Act.
- 6 -
(e) The
Act. Holder understands that this Warrant and the Shares issuable upon exercise hereof have not been registered under the Act or registered
or qualified under the securities laws of any state in reliance upon specific exemptions therefrom, which exemptions depend upon, among
other things, the bona fide nature of the Holder’s investment intent as expressed herein. Holder understands that the Company is
under no obligation to so register or qualify this Warrant, the Shares or such other securities. Holder understands that this Warrant
and the Shares issued upon any exercise hereof are “restricted securities” under applicable federal and state securities laws
and must be held indefinitely unless subsequently registered under the Act and registered or qualified under applicable state securities
laws, or unless exemption from such registration and qualification are otherwise available. Holder is aware of the provisions of Rule
144 promulgated under the Act.
5.2 No
Stockholder Rights. Without limiting any provision of this Warrant, Xxxxxx agrees that as a Holder of this Warrant it will not have
any rights (including, but not limited to, voting rights) as a stockholder of the Company with respect to the Shares issuable hereunder
unless and until the exercise of this Warrant and then only with respect to the Shares issued on such exercise.
SECTION 6. MISCELLANEOUS.
6.1 Term;
Automatic Cashless Exercise Upon Expiration.
(a) Term.
Subject to the provisions of Section 2.6 above, this Warrant is exercisable in whole or in part at any time and from time to time on or
before 5:00 PM, Eastern time, on the Expiration Date and shall be void thereafter.
(b) Automatic
Cashless Exercise upon Expiration. In the event that, upon the Expiration Date, the fair market value of one Share as determined in
accordance with Section 2.3 above is greater than the Exercise Price in effect on such date, then this Warrant shall automatically be
deemed on and as of such date to have been exercised pursuant to Section 2.2 above as to all Shares for which it shall not previously
have been exercised, and the Company shall, within a reasonable time following Holder’s written request, deliver a certificate,
which may be in electronic form (or, in the case of uncertificated securities, provide notice of book entry) representing the Shares issued
to Holder upon such exercise.
6.2 Legends. Each
certificate or notice of book entry evidencing Shares shall be imprinted with a legend in substantially the following form:
THE SHARES EVIDENCED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF
ANY STATE AND, EXCEPT AS SET FORTH IN THAT CERTAIN STOCK PURCHASE WARRANT DATED MARCH 8, 2024 ISSUED BY THE ISSUER TO HSBC VENTURES USA
INC., MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION
OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
6.3 Compliance
with Securities Laws on Transfer. This Warrant and the Shares issued upon exercise hereof may not be transferred or assigned in whole
or in part except in compliance with applicable federal and state securities laws by the transferor and the transferee (including, without
limitation, the delivery of investment representation letters and legal opinions reasonably satisfactory to the Company, as reasonably
requested by the Company). The Company shall not require Holder to provide an opinion of counsel in connection with a transfer by Xxxxxx
of this Warrant if the transfer is to an affiliate (as defined in Regulation D promulgated under the Act) of Holder, provided that such
affiliate is an “accredited investor” (as defined in Regulation D promulgated under the Act).
- 7 -
6.4 Transfer
Procedure. Subject to the provisions of Section 6.3 and upon providing the Company with written notice, Holder may transfer all or
part of this Warrant or the Shares issued upon exercise of this Warrant to any transferee; provided that in connection with any such transfer,
Holder will give the Company notice of the portion of the Warrant and/or Shares being transferred with the name, address and taxpayer
identification number of the transferee, and Xxxxxx will surrender this Warrant, or the certificates or other evidence of such Shares
or other securities, to the Company for reissuance to the transferee(s) (and to Holder if applicable); and provided further, that any
transferee shall make substantially the representations set forth in Section 5.1 above and shall agree in writing with the Company to
be bound by all of the terms and conditions of this Warrant.
6.5 Notices.
All notices and other communications hereunder from the Company to the Holder, or vice versa, shall be deemed delivered and effective
(i) when given personally, (ii) on the third (3rd) Business Day after being mailed by first-class registered or certified mail, postage
prepaid, (iii) upon actual receipt if given by electronic mail and such receipt is confirmed in writing electronically by the recipient,
or (iv) on the first Business Day following delivery to a reliable overnight courier service, courier fee prepaid, in any case at such
address as may have been furnished to the Company or Holder, as the case may be, in writing by the Company or such Holder from time to
time in accordance with the provisions of this Section 6.5. All notices to Holder shall be addressed as follows until the Company receives
notice of a change of address in connection with a transfer or otherwise:
HSBC Ventures USA Inc.
c/o CRE Servicing
Xxxxxx U Building
000 Xxx Xxxxxxxxxx Xxxxxx
Buffalo, NY 14210
Email: xxxxxxxxxxxxx@xx.xxxx.xxx
With copies to:
HSBC Ventures USA Inc.
Attention: Loan Operations
000 Xxxxxxxxxx Xxxx, 0xx Floor
Jersey City, NJ 07310
Email: xxxxxxxxxxxx@xx.xxxx.xxx
HSBC Bank USA, N.A.
Attention: Security Services – Operations
Manager
000 Xxxxx Xxxxxx
New York, NY 10018
All notices to the Company shall
be addressed as follows until Xxxxxx receives notice of a change in address:
Koru Medical Systems, Inc.
Attn: Chief Financial Officer
000 Xxxxxxxxx Xxxxx
Mahwah, NJ 07430
Telephone: (845) 469-
Email: xxxxxx@xxxxxxxxxxx.xxx
With a copy (which shall not constitute
notice) to:
Xxxxx Xxxxxx Xxxxx Xxxxxxxxx LLC
Attn: Xxxxxxx X. Xxxxxx, Esq.
- 8 -
Two Xxxxx Square
000 X. 00xx Xxxxxx, Xxxxx 000
Philadelphia, PA 19103
Telephone: (000) 000-0000
Email: xxxxxxx@xxxxxxx.xxx
6.6 Amendment
and Waiver. This Warrant may be amended and any provision hereof waived (either generally or in a particular instance and either retroactively
or prospectively) only by an instrument in writing signed by Xxxxxx and the Company.
6.7 Attorneys’
Fees. In the event of any dispute between Xxxxxx and the Company arising out of, based upon or related to this Warrant, the party
prevailing in such dispute shall be entitled to collect from the other party all reasonable, documented, out-of-pocket costs and expenses
incurred in connection such dispute, including, but not limited to, reasonable attorneys’ fees and disbursements.
6.8 Counterparts;
Electronic Signatures; Status as Certificated Security. This Warrant may be executed by one or more of the parties hereto in any number
of separate counterparts, all of which together shall constitute one and the same instrument. The Company, Xxxxxx and any other party
hereto may execute this Warrant by electronic means and each party hereto recognizes and accepts the use of electronic signatures and
the keeping of records in electronic form by any other party hereto in connection with the execution and storage hereof. To the extent
that this Warrant or any agreement subject to the terms hereof or any amendment hereto is executed, recorded or delivered electronically,
it shall be binding to the same extent as though it had been executed on paper with an original ink signature, as provided under applicable
law, including, without limitation, any state law based on the Uniform Electronic Transactions Act. The fact that this Warrant is executed,
signed, stored or delivered electronically shall not prevent the transfer by any Holder of this Warrant pursuant to Section 6.4 or the
enforcement of the terms hereof. To the extent that the original of this Warrant is an electronic original, this Warrant, and any copies
hereof, shall NOT be deemed to be a “certificated security” within the meaning of Section 8102(a)(4) of the California Commercial
Code. Physical possession of the original of this Warrant or any paper copy thereof shall confer no special status to the bearer thereof.
6.9 Headings.
The headings in this Warrant are for purposes of reference only and shall not limit or otherwise affect the meaning of any provision of
this Warrant.
6.10 Business
Days. “Business Day” is any day that is not a Saturday, Sunday or a day on which banks in New York City
are required to be closed.
SECTION 7. GOVERNING LAW, VENUE, JURY TRIAL WAIVER.
7.1 Governing
Law. This Warrant and the parties’ respective rights and obligations hereunder shall be governed by and construed in accordance
with (i) the General Corporation Law of the State of Delaware, as to all matters within its scope, and (ii) otherwise, the internal domestic
laws of the State of New York, without giving effect to its principles regarding conflicts of law.
7.2 Jurisdiction
and Venue. The Company and Holder each submit to the non-exclusive jurisdiction of the State and Federal courts in New York, NY; provided,
however, that nothing in this Warrant shall be deemed to operate to preclude Holder from bringing suit or taking other legal action in
any other jurisdiction to enforce a judgment or other court order in favor of Xxxxxx. The Company expressly submits and consents in advance
to such jurisdiction in any action or suit commenced in any such court, and the Company hereby waives any objection that it may have based
upon lack of personal jurisdiction, improper venue, or forum non conveniens and hereby consents to the granting of such legal or equitable
relief as is deemed appropriate by such court. The Company hereby waives personal service of the summons, complaints, and other process
issued in such action or suit and agrees that service of such summons, complaints, and other process may be made in accordance with Section
6.5 of this Warrant.
- 9 -
7.3 Jury
Trial Waiver. TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, THE COMPANY AND HOLDER EACH WAIVE THEIR RIGHT TO A JURY TRIAL
OF ANY CLAIM OR CAUSE OF ACTION ARISING OUT OF, BASED UPON OR RELATED TO THIS WARRANT, INCLUDING CONTRACT, TORT, BREACH OF DUTY AND ALL
OTHER CLAIMS. THIS WAIVER IS A MATERIAL INDUCEMENT FOR THE PARTIES’ AGREEMENT TO THIS WARRANT. EACH PARTY HAS REVIEWED THIS WAIVER
WITH ITS COUNSEL.
7.4 Survival.
This Section 7 shall survive the termination of this Warrant.
[Remainder of page left blank intentionally]
[Signature page follows]
- 10 -
IN
WITNESS WHEREOF, the parties have caused this Stock Purchase Warrant to be executed by their duly authorized representatives effective
as of the Issue Date written above.
“COMPANY”
KORU MEDICAL SYSTEMS, INC.
By: /s/ Xxxxxx Xxxxx
Name: Xxxxxx Xxxxx
Title: Chief Financial Officer
“HOLDER”
HSBC VENTURES USA INC.
By: /s/ Xxxx Xxxx
Name: Xxxx Xxxx
Title: Vice President
- 11-
